View the LUCIBRU registration information details.
Back to drug list
ItemsDrug Registration information
ID1698
No1698
Brand NameLUCIBRU
IngredientsIBRUTINIB 140 MG
Dosage FormTABLET
Primary PackagingBOTTLE
Storage
Shelf Life2 YEARS
Pack SizeBOX OF 120'S/BOTTLE
Dispensing Category
ATC Classification
Pharmaceutical Class
IndicationsADULT PATIENTS WITH MANTLE CELL LYMPHOMA WHO HAVE RECEIVED AT LEAST ONE PRIOR THERAPY, CHRONIC LYPHOCYTIC LEUKEMIA
Contraindications
Side Effects
Unit Price
EDLNULL
DescriptionYELLOW FILM COATED TABLET
Note
License OwnerLUCIUS PHARMACEUTICALS(LAO) CO.,LTD
ManufacturerLUCIUS PHARMACEUTICALS(LAO) CO.,LTD
CountryLAOS
Import Registration No
Import Registration Date
ActivityCERTIFICATE RELEASED
Applied Date
FDD Registration No07 L 1141/24
FDD Registration Date12/07/2024
Expiry Date11/07/2027
Back to drug list
ADB ASEAN COVID-19 Laos JICA KOICA Global Fund WFP UHS Laos World Bank MOH Laos UNODC WHO SIDA